Biomarkers of infection for the differential diagnosis of pleural effusions Source: Eur Respir J 2009; 34: 1383-1389 Year: 2009
Can VEGF be used in differential diagnosis of pleural effusions? Source: Eur Respir J 2007; 30: Suppl. 51, 565s Year: 2007
Elevated IL-18 levels in exudative pleural effusions, correlation with markers of pleural inflammation Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours Year: 2009
The implication of C-reactive protein in differentiation of various pleural effusion etiologies Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008
Investigation of CD14 with toll like receptors expression in pleural effusion for detection of thoracic disorders Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma Source: Eur Respir J 2010; 36: 1099-1105 Year: 2010
The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017
The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Correlation between pleural fluid and serum C-reactive protein in patients with pleural effusion due to different etiologies Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician Year: 2020
Neurotrophin protein expression in pleural effusions Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools Year: 2009
Importance of complement C3-C4 levels on differential diagnosis of pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 688s Year: 2005
Diagnostic usefulness of C reactive protein levels in pleural effusions of malignant and non malignant origin Source: Eur Respir J 2007; 30: Suppl. 51, 431s Year: 2007
Interelukin-17A is elevated in parapneumonic pleural effusions and is associated with neutrophils and VEGF Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006
Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM) Source: Eur Respir J 2004; 24: Suppl. 48, 81s Year: 2004
Is pleural VEGF a useful parameter? Source: Annual Congress 2007 - Pleural malignancy Year: 2007
Angiopoietin-2 levels are elevated in exudative pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 448s Year: 2005
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012
Interleukin-8 and other mediators are related to tumour burden in malignant pleural effusions (MPE) Source: Eur Respir J 2007; 30: Suppl. 51, 103s Year: 2007
The diagnostic value of pleural fluid C-reactive protein level in pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002
C-reactive protein in differentiation between tuberculous and malignant pleural effusions Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011